top of page

Carbon Credits for Hospitals in India: What to Cut First, What to Offset

C² Team
Sep 2
4 min read

India's carbon market is now operational, but it was not built with hospitals in mind. If you run sustainability or procurement for an Indian hospital group, the useful question is not how many carbon credits you are forced to buy. It is which tonnes you should be eliminating for free before you buy anything at all.

Hospitals are not CCTS-obligated entities

Compliance obligations under India's Carbon Credit Trading Scheme came into force from FY2025-26 for roughly 490 entities across seven energy-intensive sectors. Aluminium, cement, chlor-alkali and pulp and paper were notified in October 2025; petroleum refining, petrochemicals and textiles followed in January 2026. Iron and steel and fertiliser targets are still pending.

Healthcare appears on none of those lists. No Indian hospital holds a legally binding emission-intensity target, and none faces a shortfall purchase on the 31 July compliance date. Pressure on hospitals comes instead from SEBI's BRSR framework, from accreditation bodies folding sustainability into their standards, and from lenders and international partners reading those disclosures.

That distinction changes the commercial logic. An obligated cement plant buys credits because the alternative is a penalty. A hospital buys them because it has made a public claim it needs to defend, which sets a much higher bar for credit quality and a much lower tolerance for offsetting emissions it could simply stop producing.

The cheapest tonnes in a hospital sit in the operating theatre

Inhaled anaesthetics are Scope 1 emissions, vented largely unchanged into the atmosphere, and they are extraordinarily potent. On a 100-year basis, desflurane has a global warming potential of 2,540, isoflurane 539, nitrous oxide 273 and sevoflurane 144. Nitrous oxide persists in the atmosphere for roughly 114 years. The American Society of Anesthesiologists puts inhaled anaesthetics at around 5% of hospital emissions and up to half of perioperative emissions, with desflurane alone responsible for about 80% of the greenhouse effect from volatile anaesthetic pollution.

Health systems in the UK, New Zealand and the United States have separately found that 77% to 95% of nitrous oxide is lost to manifold and pipeline leaks before it ever reaches a patient. That is a Scope 1 line item with no clinical benefit whatsoever.

Four interventions remove most of this at negligible cost:

  • Take desflurane off the formulary unless there is a clear clinical indication

  • Decommission central nitrous oxide pipelines and switch to portable cylinders kept closed between uses

  • Minimise fresh gas flows, including on induction

  • Use total intravenous or regional anaesthesia where clinically appropriate

Run the marginal abatement comparison honestly before you buy anything. High-integrity credits do not clear cheaply: CORSIA-eligible credits have traded between USD 15 and USD 22 per tonne since September 2025, against USD 1 to USD 14 for most other categories. Paying that to offset gas losses you could stop with a formulary decision is a procurement failure, not a climate strategy.

The 24x7 load is where offsetting starts to make sense

Hospitals cannot load-shift. HVAC alone can account for 40-60% of energy use in a large tertiary-care facility, with theatres, ICUs and imaging running continuously. The IFC estimates green hospital design cuts energy and water use by around 30% against conventional builds, and Indian operators are proving the efficiency case. Fortis Healthcare reports a 13% reduction in energy consumption per occupied bed over three years, with FY26 interventions alone cutting per-bed Scope 1 and Scope 2 emissions by 8.7% and eliminating roughly 4,435 tonnes of CO2. Apollo's Project Virya, spanning 40 hospitals, has delivered Rs 297 crore in energy cost savings over two years.

What efficiency and renewable procurement cannot reach is your genuine offset envelope: standby diesel generation, refrigerant leakage, the medical gases that remain clinically necessary, biomedical waste treatment, and patient and staff travel. Size your purchase against that residual, not your gross footprint. The same logic governs any always-on facility, and our note on carbon credits for data centres works through the identical problem on the Scope 2 side.

Which credit types actually fit a hospital buyer

  1. Domestic CCTS offset credits. BEE approved ten sectors for the offset mechanism in September 2024 and published twelve Phase 1 methodologies in January 2025, with construction, fugitive emissions, solvent use and CCUS to follow in Phase 2. The Indian Carbon Market Portal, launched on 21 March 2026, registers non-obligated entities too, making this the cleanest domestic provenance available to an Indian hospital.

  2. Durable removals. Afforestation, mangrove restoration and biochar cost more, but they match the permanence of the long-lived gases you are offsetting. Buy small volumes against the anaesthetic residual you cannot clinically eliminate.

  3. Waste and methane avoidance. Landfill methane recovery and compressed biogas sit closest to a hospital's own waste narrative and are already covered by approved Indian methodologies.

  4. Unbundled renewable energy credits. Easiest to buy, hardest to defend in an assurance conversation. Treat them as a last resort rather than a default.

Quality is the whole game here, because a hospital brand carries reputational exposure an industrial buyer does not. Screen every credit against integrity criteria before it reaches your board.

Sizing, contracting and retirement

Borrow the metric Fortis uses internally and measure per occupied bed rather than in absolute terms, so activity growth does not disguise performance. Then work in sequence:

  • Build a Scope 1 and Scope 2 inventory with anaesthetic and medical gases broken out separately

  • Eliminate the free tonnes before pricing a single credit

  • Contract renewable power against the base load

  • Size credits only against the verified residual

  • Retire in your own name and publish the serial numbers

One contracting caution: analysis by Rubix Data Sciences found only about a third of Indian carbon projects reach registration, even though India issued more than 375 million credits between 2010 and 2025. Contract on delivered and retired tonnes, never on projected issuance.

Csquare helps Indian healthcare groups build defensible carbon inventories, cut the emissions worth cutting, and source verified carbon credits for the rest. Talk to our team.

 
 
 

Recent Posts

See All

Comments


bottom of page